RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation
Science Advances · 2026
DOI: 10.1126/sciadv.adz6907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Pushpamali De Silva und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Killer Cells, Natural, TOR Serine-Threonine Kinases, Colorectal Neoplasms, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Institute of Health grant.
Abstract (Originalsprache)
The RNF43 p.G659fs ( RNF43 659mut ) mutation occurs in 8% of colorectal cancers (CRCs) and is enriched in microsatellite instability–high (MSI-H) tumors. Although RNF43 659mut promotes tumor growth through phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin (PI3K/AKT/mTOR) activation independent of WNT signaling, its immunologic effects are poorly defined. We show that RNF43 659mut shapes an immunosuppressive natural killer (NK) cell landscape in MSI-H CRC. Single-cell RNA sequencing and multiplex immunohistochemistry revealed increased NK cell infiltration in RNF43 659mut tumors, yet these cells displayed inhibitory phenotypes. Bulk RNA sequencing and flow cytometry of NK cells cocultured with RNF43 659mut isogenic lines and MSI-H patient-derived organoids demonstrated reduced functional NK subsets, decreased activation markers, increased inhibitory receptors, and impaired cytotoxicity. Mechanistically, RNF43 659mut -mediated PI3K/AKT activation induced HLA-E expression, suppressing NK cell function. Pharmacological or small interfering RNA–mediated PI3K/AKT inhibition restored NK cell activity and enhanced tumor cell killing. Spatial analysis of MSI-H patient tumors revealed close proximity between NKG2A + NK cells and HLA-E + tumor cells, which were themselves adjacent to PI3K/AKT-activated tumor cells, highlighting a localized immunosuppressive niche. These findings uncover an immune evasion mechanism in MSI-H CRC, implicating the PI3K/AKT-HLA-E/NKG2A axis as a promising therapeutic target to overcome immunotherapy resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.
- Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
ORCID-Profile: Pushpamali De Silva, Samantha Fitzgerald, Jules Cazaubiel, Kristin Qian, Matan Hofree, Jia-Ren Lin, Mariana Lopez Leon, Phuong Vu Mai Ho, Juha P Väyrynen, Kosuke Matsuda, Tomotaka Ugai, Dane Ford-Roshon, Pratyusha Bala, Nir Hacohen, Kimmie Ng, Jonathan A Nowak, Shuji Ogino, Peter K Sorger, Marios Giannakis
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Institute of Health grant
- The Cancer Research UK Grand Challenge
- Crush Colon Cancer Fund
- The American Cancer Society Clinical Research Professor Award
- Project P Fund
- Brigham and Women’s Hospital Faculty Career Development Award
Zitieren
APA
De Silva, P., Fitzgerald, S., Cazaubiel, J., Qian, K., Hofree, M., Lin, J. R., Pelletier, R., Lopez Leon, M., Ho, P. V. M., Takashima, Y., Väyrynen, J. P., Matsuda, K., Ugai, T., Ford-Roshon, D., Bala, P., Hacohen, N., Ng, K., Nowak, J. A., Ogino, S., …, & Giannakis, M. (2026). RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation. Science Advances. https://doi.org/10.1126/sciadv.adz6907
Vancouver
De Silva P, Fitzgerald S, Cazaubiel J, Qian K, Hofree M, Lin JR, et al. RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation. Science Advances. 2026. doi:10.1126/sciadv.adz6907
BibTeX
@article{DeSilva2026,
author = {De Silva, Pushpamali and Fitzgerald, Samantha and Cazaubiel, Jules and Qian, Kristin and Hofree, Matan and Lin, Jia-Ren and Pelletier, Roxanne and Lopez Leon, Mariana and Ho, Phuong Vu Mai and Takashima, Yasutoshi and Väyrynen, Juha P and Matsuda, Kosuke and Ugai, Tomotaka and Ford-Roshon, Dane and Bala, Pratyusha and Hacohen, Nir and Ng, Kimmie and Nowak, Jonathan A and Ogino, Shuji and Sorger, Peter K and Giannakis, Marios},
title = {RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adz6907}
}
EUVIMED